top of page

Afferent Medical Solutions Completes Seed Round Funding, Propelling Innovation in Non-Invasive Medical Solutions

Nikolai V Gourine

25 Feb 2021

Afferent Medical Solutions celebrates the successful closure of its seed round funding, marking a significant milestone in its mission to innovate non-invasive medical solutions. With investor support, Afferent is poised to accelerate research and development efforts, driving forward its vision of revolutionizing healthcare through cutting-edge technology.

Afferent Medical Solutions is delighted to announce the successful closure of its seed round funding. This achievement marks a pivotal moment in Afferent's journey, providing essential support to advance its mission of developing novel, non-invasive, device-based medical solutions.

The completion of the seed round funding represents a significant vote of confidence from investors, validating Afferent's innovative approach and groundbreaking technology. With this financial backing, Afferent is poised to accelerate its research and development efforts, further refining its proprietary solutions aimed at addressing critical healthcare challenges.

"We are incredibly excited to have successfully closed our seed round funding," said Everard Mascarenhas at Afferent Medical Solutions. "This achievement not only demonstrates the belief of our investors in our vision but also signifies a major step forward in our quest to revolutionize healthcare through innovation."

The funds raised will be instrumental in supporting Afferent's ongoing initiatives, including advancing research, expanding clinical trials, and enhancing product development. By harnessing the power of cutting-edge technology and scientific expertise, Afferent remains dedicated to bringing transformative medical solutions to patients around the world.

For media inquiries or further information, please contact:

Nikolai V Gourine

bottom of page